(Q35164282)

6 August 2017

1 reference

title

The association of nephrolithiasis with cystic fibrosis (English)

1 reference

6 August 2017

0 references

David S Goldfarb

2

0 references

author name string

Eric M Gibney

series ordinal

1

1 reference

6 August 2017

1 July 2003

1 reference

American Journal of Kidney Diseases

6 August 2017

1 reference

6 August 2017

42

1 reference

6 August 2017

1

1 reference

6 August 2017

1-11

1 reference

Kidney stones and cystic fibrosis

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Nephrolithiasis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Demographic and geographic variability of kidney stones in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Regional variation in nephrolithiasis incidence and prevalence among United States men

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Renal stone epidemiology: A 25-year study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Frequency of urolithiasis in a prepaid medical care program

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Urate and calcium stones--picking up a drop of mercury with one's fingers?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Studies on the cause of hyperuricosuria in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Increased risk of nephrolithiasis in patients with steatorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Importance of the colon in enteric hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalate and calcium excretion in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Altered calcium homeostasis in adults with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Hypercalciuria and nephrocalcinosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Nephrocalcinosis in children: a retrospective survey. Members of the Arbeitsgemeinschaft für pädiatrische Nephrologie.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Microscopic nephrocalcinosis in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Immunoreactive calmodulin in cystic fibrosis kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Renal problems after lung transplantation of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

ClC and CFTR chloride channel gating

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Isolated hypercalciuria with mutation in CLCN5: Relevance to idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

From stones to bones: the biology of ClC chloride channels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Magnesium status of patients with renal stones and its effect on urinary citrate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Voluntary dehydration and heat intolerance in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Preventing dehydration in children with cystic fibrosis who exercise in the heat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Urinary Excretion of Citrate, Glycosaminoglycans, Magnesium and Zinc in Relation to Age and Sex in Normal Subjects and in Patients who form Calcium Stones

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Abnormalities in zinc homeostasis in young infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalate degradation by gastrointestinal bacteria from humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Intestinal colonization of laboratory rats with Oxalobacter formigenes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalobacter formigenes and its potential role in human health.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Conductive pathways for chloride and oxalate in rabbit ileal brush-border membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Oxalate-degrading Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900403-7

7 January 2021

10.1016/S0272-6386(03)00403-7

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12830451